UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 79

Sortiert nach

The breakthrough in vaccination: Nobel Prize in Physiology or Medicine 2023

Structural chemistry, 2024-04, Vol.35 (2), p.695-699

Hagymási, Krisztina

2024

Link zum Volltext

Verfügbarkeit prüfen

The Nobel prize in physiology and medicine – 2022

Structural chemistry, 2023-04, Vol.34 (2), p.733-736

Hagymási, Krisztina

2023

Link zum Volltext

Verfügbarkeit prüfen

The nobel prize in physiology or medicine — 2021

Structural chemistry, 2022, Vol.33 (3), p.987-990

Hagymási, Krisztina

2022

Link zum Volltext

Verfügbarkeit prüfen

Helicobacter pylori infection: New pathogenetic and clinical aspects

World journal of gastroenterology : WJG, 2014-06, Vol.20 (21), p.6386-6399

Krisztina Hagymási Zsolt Tulassay

2014

Link zum Volltext

Verfügbarkeit prüfen

The Nobel Prize in Physiology or Medicine—2020

Structural chemistry, 2021, Vol.32 (2), p.909-913

Hagymási, Krisztina

2021

Link zum Volltext

Verfügbarkeit prüfen

Systematic review and meta-analysis: proton pump inhibitors slightly decrease the severity of chronic cough

Scientific reports, 2024-05, Vol.14 (1), p.11956-11956, Article 11956

2024

Link zum Volltext

Verfügbarkeit prüfen

Morphology of the papilla can predict procedural safety and efficacy of ERCP-a systematic review and meta-analysis

Scientific reports, 2024-03, Vol.14 (1), p.7341-7341, Article 7341

2024

Link zum Volltext

Verfügbarkeit prüfen

Update on the pharmacogenomics of proton pump inhibitors

Pharmacogenomics, 2011-06, Vol.12 (6), p.873-888

2011

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of COVID-19 Vaccination with mRNA Vaccines for Patients with Cirrhosis in Hungary: Multicentre Matched Cohort Study

Vaccines (Basel), 2022-12, Vol.11 (1), p.50

2022

Link zum Volltext

Verfügbarkeit prüfen

Hypocalcemia on Admission Is a Predictor of Disease Progression in COVID-19 Patients with Cirrhosis: A Multicenter Study in Hungary

Biomedicines, 2023-05, Vol.11 (6), p.1541

2023

Link zum Volltext

Verfügbarkeit prüfen

Extrahepatic manifestations in chronic hepatitis C infected patients

Orvosi hetilap, 2017-04, Vol.158 (16), p.603

2017

Link zum Volltext

Verfügbarkeit prüfen

Options for non-invasive assessment of liver fibrosis based on clinical data

Orvosi hetilap, 2015-01, Vol.156 (2), p.43

2015

Link zum Volltext

Verfügbarkeit prüfen

Antioxidants--antioxidative stress: facts and questions, 2015

Orvosi hetilap, 2015-11, Vol.156 (47), p.1884

2015

Link zum Volltext

Verfügbarkeit prüfen

The Elevated De Ritis Ratio on Admission Is Independently Associated with Mortality in COVID-19 Patients

Viruses, 2022-10, Vol.14 (11), p.2360

2022

Link zum Volltext

Verfügbarkeit prüfen

Non-invasive assessment of fatty liver

Orvosi hetilap, 2015-04, Vol.156 (14), p.543

2015

Link zum Volltext

Verfügbarkeit prüfen

Various pathways leading to the progression of chronic liver diseases

Orvosi hetilap, 2016-02, Vol.157 (8), p.290

2016

Link zum Volltext

Verfügbarkeit prüfen

Tissue attenuation imaging and tissue scatter imaging for quantitative ultrasound evaluation of hepatic steatosis

Medicine (Baltimore), 2022-08, Vol.101 (33), p.e29708-e29708

2022

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Artificial Intelligence-Calculated Hepatorenal Index for Diagnosing Mild and Moderate Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease

Medicina (Kaunas, Lithuania), 2023-02, Vol.59 (3), p.469

2023

Link zum Volltext

Verfügbarkeit prüfen

The Calculation and Evaluation of an Ultrasound-Estimated Fat Fraction in Non-Alcoholic Fatty Liver Disease and Metabolic-Associated Fatty Liver Disease

Diagnostics (Basel), 2023-10, Vol.13 (21), p.3353

2023

Link zum Volltext

Verfügbarkeit prüfen

THU-103 Results froma phase 2a trial with the CD80 antagonist RhuDex as a second line treatment for primary biliary cholangitis

Journal of hepatology, 2024-06, Vol.80, p.S311-S312

2024

Link zum Volltext

Verfügbarkeit prüfen

Morphology of the papilla can predict a higher rate of post-ERCP adverse events - a systematic review and meta-analysis

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2023-11, Vol.23, p.e69-e70

2023

Link zum Volltext

Verfügbarkeit prüfen

Chronic liver diseases is an important risk factor in acute pancreatitis: systematic review and meta-analysis

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2023-11, Vol.23, p.e46-e46

2023

Link zum Volltext

Verfügbarkeit prüfen

Review of overlap syndromes in autoimmune liver diseases. Diagnostic and therapeutic difficulties

Orvosi hetilap, 2013-06, Vol.154 (24), p.923

2013

Link zum Volltext

Verfügbarkeit prüfen

Comments on “The severity of non-alcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota”

Hepatoma research, 2016-12, Vol.2 (12), p.328

2016

Link zum Volltext

Verfügbarkeit prüfen

Commentson“Theseverityofnon-alcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota”

肝癌研究（英文版）, 2016, Vol.2 (12), p.328-330

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(79)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The breakthrough in vaccination: Nobel Prize in Physiology or Medicine 2023

The Nobel prize in physiology and medicine – 2022

The nobel prize in physiology or medicine — 2021

Helicobacter pylori infection: New pathogenetic and clinical aspects

The Nobel Prize in Physiology or Medicine—2020

Systematic review and meta-analysis: proton pump inhibitors slightly decrease the severity of chronic cough

Morphology of the papilla can predict procedural safety and efficacy of ERCP-a systematic review and meta-analysis

Update on the pharmacogenomics of proton pump inhibitors

Effectiveness of COVID-19 Vaccination with mRNA Vaccines for Patients with Cirrhosis in Hungary: Multicentre Matched Cohort Study

Hypocalcemia on Admission Is a Predictor of Disease Progression in COVID-19 Patients with Cirrhosis: A Multicenter Study in Hungary

Extrahepatic manifestations in chronic hepatitis C infected patients

Options for non-invasive assessment of liver fibrosis based on clinical data

Antioxidants--antioxidative stress: facts and questions, 2015

The Elevated De Ritis Ratio on Admission Is Independently Associated with Mortality in COVID-19 Patients

Non-invasive assessment of fatty liver

Various pathways leading to the progression of chronic liver diseases

Tissue attenuation imaging and tissue scatter imaging for quantitative ultrasound evaluation of hepatic steatosis

Evaluation of Artificial Intelligence-Calculated Hepatorenal Index for Diagnosing Mild and Moderate Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease

The Calculation and Evaluation of an Ultrasound-Estimated Fat Fraction in Non-Alcoholic Fatty Liver Disease and Metabolic-Associated Fatty Liver Disease

THU-103 Results froma phase 2a trial with the CD80 antagonist RhuDex as a second line treatment for primary biliary cholangitis

Morphology of the papilla can predict a higher rate of post-ERCP adverse events - a systematic review and meta-analysis

Chronic liver diseases is an important risk factor in acute pancreatitis: systematic review and meta-analysis

Review of overlap syndromes in autoimmune liver diseases. Diagnostic and therapeutic difficulties

Comments on “The severity of non-alcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota”

Commentson“Theseverityofnon-alcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota”

Suchergebnisse filtern